Keyphrases
Bisphosphonate Therapy
25%
Bone Metastasis
100%
Breast Cancer
25%
Breast Cancer Patients
100%
Cancer Patients
25%
Cox Regression Model
25%
Creatinine
50%
Event Risk
25%
Event-free Survival
25%
Further Analysis
25%
In Cancer
25%
Initial Fracture
25%
Low Risk
25%
Multiple Myeloma
25%
N-telopeptide
25%
N-telopeptide of Type I Collagen
25%
Osteoclast Activity
100%
Overall Survival Time
25%
Patients with Breast Cancer
50%
Randomized Phase III Trial
25%
Relative Risk
25%
Skeletal-related Events
75%
Zoledronic Acid
100%
Medicine and Dentistry
Bisphosphonate
40%
Bone Metastasis
100%
Breast Cancer
100%
Collagen Type 1
20%
Creatinine
40%
Event Free Survival
20%
Multiple Myeloma
20%
Osteoclast Activity
100%
Overall Survival
20%
Pamidronic Acid
20%
Proportional Hazards Model
20%
Survival Time
20%
Telopeptide
20%
Urinary System
20%
Zoledronic Acid
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
40%
Bone Metastasis
100%
Breast Cancer
100%
Collagen Type 1
20%
Creatinine
40%
Event Free Survival
20%
Malignant Neoplasm
20%
Multiple Myeloma
20%
Overall Survival
20%
Pamidronic Acid
20%
Survival Time
20%
Telopeptide
20%
Zoledronic Acid
100%
Biochemistry, Genetics and Molecular Biology
Creatinine
100%
Event Free Survival
50%
Osteoclast Activity
100%
Overall Survival
50%
Survival Time
50%
Type I Collagen
50%
Immunology and Microbiology
Osteoclast Activity
100%
Overall Survival
100%
Survival Time
100%